{"article_title": "Healthcare Stocks: 3 Diamonds in the Rough (BDX, DGX, IPXL)", "article_keywords": ["sector", "real", "ipxl", "crowd", "johnson", "models", "outperform", "diamonds", "companies", "rough", "healthcare", "dgx", "stocks", "bdx", "market", "yettypically"], "article_url": "http://investorplace.com/2015/03/3-healthcare-stocks-to-buy-bdx-dgx-ipxl/", "article_text": "The healthcare sector got a boost this week from the Supreme Court\u2019s seemingly split view on the Affordable Care Act. The market translated the mixed opinions from the court as a signal that there are not likely to be sweeping changes to the law, which has been a bullish catalyst for healthcare stocks for more than a year.\n\nSource: \u00a9iStock.com/graffoto8\n\nFor most investors, investing in the healthcare sector means buying Johnson & Johnson (NYSE:JNJ), Merck & Co, Inc. (NYSE:MRK) or other well-known companies, which is fine.\n\nFor us, though, the real value is found by getting into the second and third layer of companies in the sector to find the real performance driving the group.\n\nDespite the outperformance and popularity of this sector, there are still a number of companies that are poised to outperform the market, according to our Behavioral Valuation models. Simply put, our models search for companies that are outperforming the market that \u201cthe crowd\u201d hasn\u2019t found, yet.\n\nTypically, these diamonds in the rough tend to outperform the market and their peers over the short-term as they are discovered for their strength, and attract a new crowd of buyers.\n\nNext Page", "article_metadata": {"description": "These 3 healthcare stocks aren't top-of-mind names like J&J and Merck, but they'll clobber their peers in the market in the short term.", "generator": "WordPress 4.4.3", "og": {"site_name": "InvestorPlace", "description": "These 3 healthcare stocks aren't top-of-mind names like J&J and Merck, but they'll clobber their peers in the market in the short term.", "title": "Healthcare Stocks: 3 Diamonds in the Rough (BDX, DGX, IPXL) | InvestorPlace", "locale": "en_US", "image": "http://investorplace.com/wp-content/uploads/2014/07/49-e1404235796123.jpg", "updated_time": "2015-03-05T17:03:49-04:00", "url": "http://investorplace.com/2015/03/3-healthcare-stocks-to-buy-bdx-dgx-ipxl/", "type": "article"}, "twitter": {"description": "These 3 healthcare stocks aren't top-of-mind names like J&J and Merck, but they'll clobber their peers in the market in the short term.", "creator": "@InvestorPlace", "image": "http://investorplace.com/wp-content/uploads/2014/07/49-e1404235796123.jpg", "title": "Healthcare Stocks: 3 Diamonds in the Rough (BDX, DGX, IPXL) | InvestorPlace", "site": "@InvestorPlace", "card": "summary"}, "robots": "noodp", "fb": {"admins": 100002035369734}, "yandex-verification": "7449d54f0a1869d7", "article": {"publisher": "https://www.facebook.com/investorplace", "section": "Stocks to Buy", "published_time": "2015-03-05T13:46:59-04:00", "modified_time": "2015-03-05T17:03:49-04:00"}, "keywords": "markets, healthcare stocks, BDX, DGX, IXPL", "google-site-verification": "5MtKaaO4K0OK-C2y-n9MKUc_WzF9GSkH0fLgruR0TKM", "pubdate": 20150305, "viewport": "width=device-width, initial-scale=1.0", "news_keywords": "markets, healthcare stocks, bdx, dgx, ixpl"}, "article_summary": "The healthcare sector got a boost this week from the Supreme Court\u2019s seemingly split view on the Affordable Care Act.\nSource: \u00a9iStock.com/graffoto8For most investors, investing in the healthcare sector means buying Johnson & Johnson (NYSE:JNJ), Merck & Co, Inc. (NYSE:MRK) or other well-known companies, which is fine.\nTypically, these diamonds in the rough tend to outperform the market and their peers over the short-term as they are discovered for their strength, and attract a new crowd of buyers.\nSimply put, our models search for companies that are outperforming the market that \u201cthe crowd\u201d hasn\u2019t found, yet.\nDespite the outperformance and popularity of this sector, there are still a number of companies that are poised to outperform the market, according to our Behavioral Valuation models."}